By Michelle RobertsDigital health editor Scientists say they may have made the biggest breakthrough in treating cervical cancer in 20 years, using a course of existing, cheap drugs ahead of usual radiotherapy treatment. Trial findings, revealed at the ESMO medical conference, show the approach cut the risk of women dying from the disease or the...
Small study concludes that caution is warranted for users of ‘high CBD, low THC’ cannabis products JOHNS HOPKINS MEDICINE In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in...
A new antiviral drug that induces mutations in the genetic material of influenza virus is highly effective in treating infection in animals and human airway tissue, a new study shows. The antiviral drug blocks RNA polymerase, the enzyme that plays a central role in replicating the genome of influenza virus, causing mutations in the viral...
by Nara Institute of Science and Technology A new study by scientists in Japan and Indonesia reports how an experimental drug agent stops cancer cells from growing. A little over a decade ago, Indonesian scientists first reported pentagamavumon-1 (PGV-1), an analogue of a molecule found in turmeric and that has been since discovered to have...
by Bob Yirka , Medical Xpress A large team of researchers affiliated with institutions across the Netherlands has begun what they call a Drug Rediscovery protocol—a clinical trial of sorts that involves giving cancer patients anticancer drugs that are not typically used for their type of cancer. In their paper published in the journal Nature,...
by Institute of Cancer Research Cancers with the same genetic weaknesses respond differently to targeted drugs depending on the tumour type of the patient, new research reveals. The study is set to prompt changes in thinking around precision medicine—because it shows that the genetics of a patient’s cancer may not always be enough to tell whether it will respond to a treatment. The researchers are already starting...
Michael Irving There are several techniques used to kill cancer, such as chemotherapy and radiotherapy, but the really tricky part is doing so without harming the rest of the body. Cytokines are small proteins that could play a part in immunotherapy, but they’ve so far not been approved for use, given their toxicity to healthy...
By Catharine Paddock PhD Fact checked by Paula Field Laboratory and animal studies have suggested that the leukemia drug nilotinib could alleviate symptoms of Parkinson’s disease. Now, using early results from a clinical trial in humans, scientists have worked out how the drug reduces toxic protein and raises dopamine levels in the brain. Loss of dopamine,...
Mvasi (bevacizumab-awwb) was found to be biosimilar to the drug Avastin (bevacizumab), the FDA said Thursday in a news release. Avastin was approved in 2004. Mvasi is approved to treat certain colorectal, lung, brain, kidney, and cervical cancers. The most common side effects of Mvasi include epistaxis, headache, hypertension, rhinitis, proteinuria, changes in taste, and...
